IL-17C regulates the innate immune function of epithelial cells in an autocrine manner

Nature Immunology

Volumn 12, Issue 12, 2011, Pages 1159-1166

  Ramirez Carrozzi, Vladimir ^a   Sambandam, Arivazhagan ^a   Luis, Elizabeth ^a   Lin, Zhongua ^a   Jeet, Surinder ^a   Lesch, Justin ^a   Hackney, Jason ^a   Kim, Janice ^a   Zhou, Meijuan ^a   Lai, Joyce ^a   Modrusan, Zora ^a   Sai, Tao ^a   Lee, Wyne ^a   Xu, Min ^a   Caplazi, Patrick ^a   Diehl, Lauri ^a   De Voss, Jason ^a   Balazs, Mercedesz ^a   Gonzalez Jr , Lino ^a   Singh, Harinder ^a   Ouyang, Wenjun ^a   Pappu, Rajita ^a   more..

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DEXTRAN SULFATE; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17C; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BINDING KINETICS; CELL STIMULATION; COLITIS; CYTOKINE RELEASE; EPITHELIUM CELL; HELPER CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; SKIN INFLAMMATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL LINE; COLITIS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-17; INTESTINAL MUCOSA; LEUKOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-17; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; SKIN;

EID: 81255158784     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2156     Document Type: Article

References (50)

1. Abraham, C. & Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140, 1729-1737 (2011).
2. Nestle, F.O., Di Meglio, P., Qin, J.Z. & Nickoloff, B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679-691 (2009).
3. Saenz, S.A., Taylor, B.C. & Artis, D. Welcome to the neighborhood: epithelial cellderived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 226, 172-190 (2008).
4. Sims, J.E. & Smith, D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89-102 (2010).
5. Kishimoto, T. IL-6: from its discovery to clinical applications. Int. Immunol. 22, 347-352 (2010).
6. Jager, A. & Kuchroo, V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 72, 173-184 (2010).
7. Blaschitz, C. & Raffatellu, M. Th17 cytokines and the gut mucosal barrier. J. Clin. Immunol. 30, 196-203 (2010).
8. Kolls, J.K. & Khader, S.A. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21, 443-448 (2010).
9. Ahmed, M. & Gaffen, S.L. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 21, 449-453 (2010).
10. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011).
11. Hymowitz, S.G. et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20, 5332-5341 (2001). (Pubitemid 32959452)
12. Ely, L.K., Fischer, S. & Garcia, K.C. Structural basis of receptor sharing by interleukin 17 cytokines. Nat. Immunol. 10, 1245-1251 (2009).
13. Liang, S.C. et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179, 7791-7799 (2007).
14. Wright, J. F. et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J. Biol. Chem. 282, 13447-13455 (2007). (Pubitemid 47100510)
15. Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001). (Pubitemid 34075378)
16. Lee, J. et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276, 1660-1664 (2001). (Pubitemid 32096603)
17. Rickel, E.A. et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181, 4299-4310 (2008).
18. Shi, Y. et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275, 19167-19176 (2000). (Pubitemid 30422887)
19. Liu, Y. et al. IL-17A and TNF-exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J. Immunol. 186, 3197-3205 (2011).
20. Aujla, S.J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 275-281 (2008). (Pubitemid 351347908)
21. Ishigame, H. et al. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119 (2009).
22. Khader, S.A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8, 369-377 (2007). (Pubitemid 46745412)
23. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55-62 (2004). (Pubitemid 38177420)
24. Yang, X. O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (2008). (Pubitemid 351679682)
25. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003). (Pubitemid 36020767)
26. Johansen, C. et al. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br. J. Dermatol. 160, 319-324 (2009).
27. Leipe, J. et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62, 2876-2885 (2010).
28. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508 (2002). (Pubitemid 34546753)
29. Hofstetter, H. H. et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol. 237, 123-130 (2005). (Pubitemid 43117208)
30. Hueber, W. et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2, 52ra72 (2010).
31. Lubberts, E. et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50, 650-659 (2004). (Pubitemid 38198849)
32. Rizzo, H.L. et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J. Immunol. 186, 1495-1502 (2011).
33. Holland, D.B., Bojar, R.A., Farrar, M.D. & Holland, K.T. Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. FEMS Microbiol. Lett. 290, 149-155 (2009).
34. Johansen, C., Riis, J.L., Gedebjerg, A., Kragballe, K. & Iversen, L. Tumor necrosis factor-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor B. J. Biol. Chem. 286, 25487-25494 (2011).
35. Wu, Q. et al. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9, 78-86 (2007). (Pubitemid 46149421)
36. Hurst, S.D. et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443-453 (2002). (Pubitemid 34686166)
37. Li, H. et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97, 773-778 (2000). (Pubitemid 30070385)
38. Yamaguchi, Y. et al. IL-17B and IL-17C are associated with TNF-production and contribute to the exacerbation of inflammatory arthritis. J. Immunol. 179, 7128-7136 (2007).
39. Spriggs, M.K. Interleukin-17 and its receptor. J. Clin. Immunol. 17, 366-369 (1997). (Pubitemid 27431975)
40. L i, T.S., Li, X.N., Chang, Z.J., Fu, X.Y. & Liu, L. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell. Signal. 18, 1287-1298 (2006). (Pubitemid 43674047)
41. Chiricozzi, A. et al. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 131, 677-687 (2011).
42. Kao, C.Y. et al. IL-17 markedly up-regulates-defensin-2 expression in human airway epithelium via JAK and NF-B signaling pathways. J. Immunol. 173, 3482-3491 (2004).
43. Abreu, M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131-144 (2010).
44. Apostolaki, M., Armaka, M., Victoratos, P. & Kollias, G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr. Dir. Autoimmun. 11, 1-26 (2010).
45. Van Maele, L. et al. TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3negCD127+ immune cells in spleen and mucosa. J. Immunol. 185, 1177-1185 (2010).
46. Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008). (Pubitemid 351206544)
47. Ma, H.L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118, 597-607 (2008).
48. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
49. Reiter, M.J., Testerman, T.L., Miller, R.L., Weeks, C.E. & Tomai, M.A. Cytokine induction in mice by the immunomodulator imiquimod. J. Leukoc. Biol. 55, 234-240 (1994). (Pubitemid 24066348)
50. Chiang, E.Y. et al. Targeted depletion of lymphotoxin-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat. Med. 15, 766-773 (2009).